During Uber’s International Women’s Day (IWD) event for women drivers in Lagos, the company announced a partnership with Healthtracka to provide self-sampling cervical cancer tests for women drivers on the platform.
According to the Nigerian Institute of Medical Research, NIMR, an estimated 36 million women aged 15 years and over, are at risk of developing cervical cancer in Nigeria.
The lack of access to health services severely impacts women – this needs to be addressed urgently as detecting symptomatic patients as early as possible gives them the best chance for successful treatment.
“We are proud to partner with Healthtracka to support women drivers by playing a role in early detection of cervical cancer. Through this collaboration, we can increase screening, support early detection of the disease and help provide some peace of mind not only for women drivers but for their communities too,” explains Tope Akinwumi, Uber Country Manager, Nigeria.
Through this partnership, women drivers in Lagos will receive an HPV Self-Sampling Kit provided by Healthtracka. This allows women drivers who are always on the road, to have the screening done at the most convenient time. Once their sample arrives in the laboratory, confidential results will be available from their secure online account in seven days. The Healthtracka team will be available on a call to explain the results and provide guidance on next steps.
During the event, Ifeoluwa Dare-Johnson, CEO at Healthtracka added, “We are pleased to team up with Uber to roll out this important initiative, which will help more women take steps to take charge of their health. With cervical cancer affecting a significant part of the population, early detection and creating awareness of the disease are important ways of making a difference.
“We believe this partnership is a step in the right direction to ensure that women have equal access to healthcare and we commend Healthtracka for the work they are doing,” concludes Akinwumi.
Author
